Posted by James
Sarcoidosis is a granuloma-forming disorder characterized by mild to severe hypercalcemia in 10% of patients, with hypercalciuria occurring in up to 50% of patients at some time during the course of their disease. For many years, it was believed that hypercalcemia and/or hypercalciuria resulted from increased sensitivity to the biological effects of vitamin D. Subsequently, the circulating concentrations of 1,25(OH)2D3 was found to be high, due to its extrarenal synthesis by macrophages in sarcoid gran- ulomata. Thus, the increased 1,25(OH)2D3 synthesis causes hypercalcemia and hypercalciuria by stimulating intestinal calcium absorption and stimulating bone resorption. The distinction between AH and sarcoidosis is best exemplified by the glucocorticoid response. Glucocorticoids are effective in the management of hypercalcemia of vitamin D toxicity and hy- percalciuria associated with sarcoidosis and other granuloma- tous conditions. Among patients with sarcoidosis, prednisolone treatment significantly decreased serum 1,25(OH)2D3 and intestinal calcium absorption, whereas this treatment was uniformly ineffective among patients with AH. Cheap generic drugs online mycanadianhealthcare.com
General Description
Renal hypercalciuria is an uncommon cause of hypercalciuric nephrolithiasis. It is believed to result from a primary impairment in the renal tubular reabsorption of calcium. The resulting transient decline in serum calcium concentration stimulates parathyroid function, which in turn enhances 1,25(OH)2D3 synthesis and intestinal calcium absorption. Biochemically, serum calcium is normal and fasting urinary calcium is high coincident with elevated serum PTH, indicative of secondary hyperparathyroidism from renal calcium leak. A disturbed function of renal proximal tubule was suggested by exaggerated calci- uric response to carbohydrate ingestion, and accentuated natri- uresis to thiazide challenge. Unlike in AH, the correction of renal calcium leak by thiazide restores normal parathyroid function and intestinal calcium absorption.
Read the rest of this entry »
Posted by James
AHRAC Gene. Prior studies have indicated that the inheritance of AH is compatible with an autosomal dominant trait. Reed et al. identified a locus on chromosome 1q23.3-24 in three kindreds with phenotypically well-defined AH. Within this region, they identified a candidate gene, the absorptive hypercal- ciuria-related adenylyl cyclase (AHRAC), on account of its association with AH and the cyclase function in the soluble cytosolic cellular fraction described in its rat ortholog. The gene is ubiquitously expressed in humans and a number of base changes have been identified. While some of these base substitutions in AHRAC can be found in the normal population, the frequency in base changes was higher in patients with AH. Figure 1 summarizes the allelic frequency of all the base changes combined. Although one can easily find single base changes in normal subjects, most patients with >4 base changes have clinical AH. canadian-medshop-247.com canadian drugstore
Past studies have shown that AHRAC clearly encodes an adenylyl cyclase and is expressed in the intestine. However, it is not well understood at present how AHRAC regulates intestinal calcium transport and how the various polymorphic variants lead to hyperabsorption of calcium. At the empirical level, the intestinal absorption is positively correlated with the number of base changes in AHRAC (Fig. 2). This finding strongly suggests that AHRAC may control intestinal calcium absorption. It is important to state that intestinal calcium absorption is a continuous variable under polygenic as well as non-genetic control. The elucidation of the function of wild type and variant AHRAC in the gut should advance our knowledge of the pathophysiology of AH.
Read the rest of this entry »
Posted by James
Absorptive hypercalciuria (AH) describes a stone-forming condition in which the primary defect is presumed to be enhanced intestinal absorption of calcium. The increased absorbed calcium transiently raises serum calcium and suppresses parathyroid function. Hypercalciuria ensues from the increased renal filtered load of calcium, and decreased renal tubular re- absorption of calcium due to parathyroid suppression. In the classic presentation (AH Type I), the syndrome is characterized biochemically by normocalcemia, normal or low serum parathyroid hormone (PTH), high intestinal calcium absorption, and hypercalciuria. Urinary calcium is high (>200 mg/day) on a diet restricted in calcium (400 mg/day) and sodium (100 mEq/day), and remains high (>300 mg/day) on a high calcium diet. In normal subjects, it is <200 mg/day on a low calcium diet and rarely exceeds 250 mg/day on a high calcium diet. Fasting urinary calcium is normal, and is appropriate for the level of parathyroid function. The intestinal hyperabsorption of calcium is unaffected by reduction of urinary calcium by thiazide, or alteration of 1,25-dihydroxyvitamin D [1,25(OH)2D3] synthesis or sensitivity by orthophosphate or steroid. AH may present itself in a less severe form (AH Type II), wherein urinary calcium is normal on a calcium-restricted diet, though elevated on a high calcium diet. canadian-healthcare-shop.com online pharmacy
It may also occur in a severe form (fasting hypercalciuria), in which fasting urinary calcium is high. Fasting hypercalciuria may reflect inadequate duration of fast, incomplete renal clearance of absorbed calcium or reduced renal tubular reabsorption of calcium from suppressed parathyroid function. In some patients, however, fasting hypercalciuria may be reflective of concomitant bone loss. Although radial shaft bone density is spared, spinal bone density has been reported to be reduced in AH type I and fasting hypercalciuria. Read the rest of this entry »
Posted by James
Introduction
Hypercalciuria is clinically important since it often accompanies the formation of calcium-containing kidney stones. Among patients with idiopathic calcium oxalate nephrolithiasis, hypercalciuria is the main determinant for the formation of calcium phosphate nidus (in the thin loops of Henle of the nephron) that may initiate calcium oxalate crystallization. The correction of hypercalciuria by thiazide or indapamide has been reported to reduce the rate of recurrent stone formation. In a risk analysis, hypercalciuria confers a higher risk for stone formation than hyperoxaluria. 1 Internet Online Drugstore cad-pharmacy.com
The pathophysiologic basis for hypercalciuria is multifactorial, involving disturbance in calcium handling at three organs – intestine, kidneys and bone. Accordingly, hypercalciuria has been classified into absorptive, renal and resorptive forms, depending on whether the principal defect is intestinal hyperab- sorption of calcium, “renal leak” of calcium or excessive bone resorption. This article will review recent advances in the pathophysiology of each of three main causes of hypercalciuria. It is understood, however, that a primary defect in calcium handling in one organ system may produce a secondary disturbance in other organ system. Moreover, in some conditions, calcium handling may be primarily disturbed in more than one organ systems.
Posted by James
We installed two waste gas scavenging systems into the operating room. This was simple and inexpensive, as the ICU is contiguous with the operating room.
An adequate scavenging device can be made by connecting the exhaust port of the ventilator to a T- piece that is attached to a 3-L reservoir bag. Wall suction is applied to the remaining limb of the T-piece until the reservoir bag partially fills with each breath, but never fully collapses. Leaks are readily detectable, since isoflurane has a characteristic pungent odor.
Since this is a nonrebreathing system, a great deal of isoflurane is vaporized hourly. The cost for 24 h of continuous use is high, but it is partially offset by decreased use of other sedatives and muscle relaxants.
Read the rest of this entry »
Posted by James
Isoflurane produces bronchodilation through (3-ad- renergic receptor stimulation, direct relaxation of bronchial smooth muscle, antagonism of the action of acetylcholine and histamine, and interference with hypocapnic bronchoconstriction. Thus, a patient who is already receiving maximum doses of standard bron- chodilators may show an additional response. As our case reports suggest, isoflurane acts rapidly and may be lifesaving while high-dose corticosteroids take effect. In contrast, ketamine, an intravenous anesthetic agent that has also been used in asthma, acts by adrenergic stimulation. Little response is seen in patients receiving large doses of P-agonists and theophylline.
There are several advantages of isoflurane over other inhalational anesthetic agents. Historically, diethyl ether and cyclopropane were used, but their extreme flammability precluded their use in electrically active environments. Isoflurane is the least fat soluble of the anesthetic vapors and has the lowest blood gas solubility coefficient. Consequently, depth of anesthesia can be most rapidly adjusted with isoflurane, and time to recovery of consciousness is short, despite prolonged use.
Read the rest of this entry »
Posted by James
Case 3
A 27 month-old-boy was admitted to the pediatric ICU for the third time suffering from an exacerbation of asthma. The day prior to hospital admission he had been exposed to grass and pollen on a farm. At a rural hospital he was given albuterol, prednisone, and oral theophylline and transferred to our hospital. En route, he received hydrocortisone 125 mg IV and albuterol inhalations. The ABG values on admission were a pH of 6.94, Pco2 of 132 mm Hg, and Po2 of 79 mm Hg. Heart rate was 168 beats per minute and RR was 22 breaths per minute. Chest roentgenogram showed marked hyperinflation with no consolidation or pneumothorax. Following sedation with fentanyl and paralysis with pancuronium bromide, he was intubated. Subsequent ABG values were pH of 7.01, Pco2 of 122 mm Hg, and Po2 of 106 mm Hg (FIo2 of 0.7). The PIP was 44 cm H20. Positive end-expiratory pressure of 4 cm H20 was added. Drug therapy included methylprednisolone 15 mg IV every eight hours, albuterol 2 jig/kg/min IY atropine 0.6-mg inhalations, and aminophylline 10 mg/h IV (theophylline levels maintained at 16 to 20 mg/L).
Read the rest of this entry »